Verified Service Provider in Mauritius
Molecular Diagnostics Labs in Mauritius
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced PCR & qPCR Capabilities
Leveraging state-of-the-art Polymerase Chain Reaction (PCR) and quantitative PCR (qPCR) instrumentation, our labs offer rapid and accurate detection of infectious diseases, genetic mutations, and pathogen identification. This enables timely and precise diagnostic decisions for a wide range of clinical and research applications across Mauritius.
Next-Generation Sequencing (NGS) Services
Pioneering Next-Generation Sequencing (NGS) in Mauritius, we unlock deeper insights into genomic and transcriptomic analysis. Our NGS platforms support applications such as pathogen surveillance, cancer genomics, microbiome profiling, and personalized medicine, empowering healthcare providers and researchers with unprecedented molecular information.
Robust Quality Assurance & Accreditation
Committed to the highest standards of analytical integrity, our molecular diagnostics labs adhere to stringent Quality Assurance (QA) protocols and pursue international accreditations. This ensures the reliability, reproducibility, and accuracy of all test results, providing confidence to clinicians, patients, and public health initiatives throughout Mauritius.
What Is Molecular Diagnostics Labs In Mauritius?
Molecular diagnostics laboratories in Mauritius employ advanced techniques to analyze biological samples at the molecular level, primarily focusing on DNA, RNA, and protein analysis. These sophisticated laboratories are instrumental in identifying pathogens, assessing genetic predispositions to diseases, monitoring treatment efficacy, and informing personalized medicine approaches. The service involves the extraction and purification of nucleic acids or proteins from samples such as blood, tissue, saliva, or urine, followed by their analysis using methods like Polymerase Chain Reaction (PCR), next-generation sequencing (NGS), and microarrays. The precision and sensitivity of molecular diagnostics enable the detection of biomarkers that are indicative of disease, even at very early stages or at low concentrations.
| Typical Use Cases | Diagnostic Methodologies Employed | Clinical Significance |
|---|---|---|
| Infectious Disease Diagnosis: Detection of pathogens like SARS-CoV-2, influenza, HIV, Hepatitis B/C, tuberculosis, and emerging infectious agents. | Real-time PCR (RT-PCR), qualitative PCR, multiplex PCR, nucleic acid sequencing. | Rapid and accurate identification of causative agents, facilitating prompt treatment initiation, preventing disease spread, and guiding public health interventions. |
| Genetic and Hereditary Disease Screening: Identification of mutations associated with cystic fibrosis, sickle cell anemia, Thalassemia, BRCA gene mutations (for cancer risk), and others. | PCR-based genotyping, Sanger sequencing, fragment analysis, microarray analysis. | Enables diagnosis, carrier identification for family planning, risk assessment, and informed genetic counseling. |
| Oncology and Cancer Biomarker Detection: Profiling of tumors for mutations (e.g., EGFR, KRAS, BRAF), gene amplifications, and fusions to guide targeted therapies and immunotherapy. | NGS, FISH (Fluorescence In Situ Hybridization), pyrosequencing, PCR-based mutation detection. | Personalized cancer treatment, prediction of response to specific drugs, monitoring of treatment efficacy, and detection of minimal residual disease. |
| Pharmacogenomics: Determination of an individual's genetic makeup to predict drug metabolism, efficacy, and adverse reaction risk. | Allele-specific PCR, SNP genotyping, NGS. | Optimization of drug dosage, selection of the most effective medication, and minimization of adverse drug events. |
| Forensic and Paternity Testing: DNA profiling for identification and establishment of biological relationships. | STR (Short Tandem Repeat) analysis, SNP analysis. | Crucial for legal proceedings, identification of victims, and establishment of familial ties. |
Who Needs Molecular Diagnostics in Mauritius?
- Individuals with suspected infectious diseases: To rapidly and accurately identify viral, bacterial, or parasitic pathogens for timely treatment and public health surveillance.
- Patients with inherited or genetic disorders: For diagnosis, carrier screening, and prenatal testing to understand and manage genetic conditions.
- Oncology patients: For tumor profiling to identify specific genetic mutations that can guide targeted therapies and predict treatment response.
- Individuals undergoing organ transplantation: To assess compatibility and monitor for rejection or opportunistic infections.
- Public health agencies and researchers: For epidemiological studies, outbreak investigations, and the development of new diagnostic and therapeutic strategies.
- Healthcare providers: To inform clinical decision-making, optimize treatment plans, and improve patient outcomes.
Who Needs Molecular Diagnostics Labs In Mauritius?
Molecular diagnostics laboratories in Mauritius are essential for providing advanced and precise diagnostic services that go beyond traditional methods. These labs play a crucial role in identifying diseases at a molecular level, enabling earlier detection, more accurate diagnoses, and the development of personalized treatment plans. This advanced capability is vital for public health initiatives, research, and for individuals seeking definitive answers to complex health concerns.
| Customer/Department | Specific Needs/Applications | Benefits of Molecular Diagnostics |
|---|---|---|
| Hospitals (Public and Private) | Infectious disease testing (COVID-19, HIV, Hepatitis, Tuberculosis, STIs), genetic testing for inherited diseases, cancer biomarker identification, transplant matching, prenatal screening. | Early and accurate diagnosis, targeted therapies, improved patient outcomes, reduced hospital stays, efficient outbreak management. |
| Clinics and Diagnostic Centers | Specialized testing for complex conditions, routine screening for genetic predispositions, confirmation of diagnoses from referring physicians. | Enhanced diagnostic capabilities, wider range of services, increased patient trust, potential for specialized niche services. |
| Research Institutions and Universities | Genomic studies, disease mechanism research, drug discovery and development, epidemiological surveillance, population genetics. | Cutting-edge research, contribution to scientific knowledge, development of new diagnostic and therapeutic tools, training of future scientists. |
| Government Health Agencies | Public health surveillance (epidemics/pandemics), disease outbreak investigations, monitoring antimicrobial resistance, screening of blood donations, national health surveys. | Effective public health policy formulation, rapid response to health threats, prevention of disease spread, improved national health security. |
| Pharmaceutical and Biotechnology Companies | Companion diagnostics development, clinical trial support, drug efficacy testing, personalized medicine research, pharmacogenomics. | Accelerated drug development, identification of patient populations likely to respond to specific treatments, regulatory compliance. |
| Veterinary Clinics and Animal Health Services | Detection of animal infectious diseases, genetic testing for animal breeding, disease outbreak investigations in livestock and companion animals, food safety testing. | Improved animal health and welfare, prevention of zoonotic diseases, support for the agricultural sector, enhanced food security. |
Target Customers and Departments for Molecular Diagnostics Labs in Mauritius
- Hospitals (Public and Private)
- Clinics and Diagnostic Centers
- Research Institutions and Universities
- Government Health Agencies
- Pharmaceutical and Biotechnology Companies
- Veterinary Clinics and Animal Health Services
Molecular Diagnostics Labs Process In Mauritius
The molecular diagnostics laboratory process in Mauritius, like in many other regions, follows a structured workflow to ensure accurate and timely results. This process begins with an inquiry from a healthcare provider or patient and extends through sample collection, testing, and reporting of findings. The specific implementation may vary slightly between laboratories, but the core stages remain consistent, emphasizing quality control and regulatory compliance.
| Stage | Description | Key Activities | Responsible Personnel | Potential Challenges/Considerations |
|---|---|---|---|---|
| Inquiry & Test Ordering | The process starts when a clinician, healthcare facility, or sometimes a patient seeks a specific molecular diagnostic test. | Clinician consultation, selection of appropriate test based on suspected condition, generation of a referral/request form. | Clinician, Healthcare Professional | Accurate test selection, understanding of test indications and limitations, availability of specific tests. |
| Sample Collection & Transportation | The correct biological sample is collected from the patient and transported to the laboratory under appropriate conditions. | Collection of blood, saliva, swab (nasal, throat), tissue, or other biological fluids. Proper labeling of sample. Use of appropriate collection devices and transport media. Adherence to temperature and time constraints. | Healthcare Professional (Nurse, Doctor, Phlebotomist) | Sample integrity, contamination risk, patient comfort, timely delivery, adherence to cold chain if required. |
| Sample Reception & Accessioning | Upon arrival at the lab, samples are received, logged, and assigned a unique identifier. | Verification of sample type and integrity. Checking for proper labeling and associated documentation. Logging the sample into the Laboratory Information Management System (LIMS). Assigning a unique laboratory accession number. | Laboratory Receptionist, Laboratory Technologist | Mislabeling, incomplete documentation, sample degradation, LIMS errors. |
| Pre-analytical Processing (if applicable) | Some samples may require preliminary steps before nucleic acid extraction, depending on the sample type and assay. | Centrifugation of blood to obtain plasma or serum, dilution of samples, etc. | Laboratory Technologist | Proper handling to avoid contamination or degradation. |
| Nucleic Acid Extraction | The genetic material (DNA or RNA) is isolated and purified from the biological sample. | Using manual or automated methods. Application of lysis buffers, purification kits, and reagents. Ensuring high yield and purity of nucleic acids. | Laboratory Technologist, Molecular Biologist | Reagent quality, contamination, incomplete lysis, low yield, sample inhibitors. |
| Amplification (e.g., PCR, RT-PCR) | The extracted nucleic acid is amplified to create millions of copies of specific target sequences. | Preparation of reaction mixtures containing primers, nucleotides, polymerase enzyme, and buffer. Running the amplification reaction in a thermal cycler (e.g., PCR, RT-PCR). | Laboratory Technologist, Molecular Biologist | Reagent contamination (DNA/RNA), suboptimal reaction conditions, inhibitor presence, equipment malfunction. |
| Detection & Analysis | The amplified genetic material is detected and analyzed to identify the presence or absence of specific targets. | Utilizing techniques like gel electrophoresis, real-time PCR (fluorescence detection), or sequencing. Analyzing raw data generated by the instruments. | Laboratory Technologist, Molecular Biologist | Sensitivity and specificity of the assay, instrument calibration, data interpretation errors, cross-contamination. |
| Data Interpretation & Reporting | The results of the analysis are interpreted by qualified personnel and a formal report is generated. | Comparing results against established controls and reference ranges. Clinical correlation with patient's history. Preparation of a comprehensive report including test performed, results, interpretation, and recommendations (if applicable). | Medical Laboratory Scientist, Pathologist, Molecular Pathologist | Misinterpretation of complex results, reporting errors, delay in reporting, lack of clinical context. |
| Quality Assurance & Control | Continuous monitoring and implementation of quality control measures throughout the entire process. | Use of positive and negative controls, proficiency testing, calibration of instruments, validation of new assays, adherence to Standard Operating Procedures (SOPs), documentation of all steps. | Quality Manager, All Laboratory Staff | Inconsistent QC results, deviation from SOPs, lack of adequate training, insufficient documentation. |
| Billing & Record Keeping | Accurate billing for services rendered and meticulous maintenance of all patient and laboratory records. | Generating invoices based on tests performed and patient/insurance information. Maintaining secure and retrievable records for a specified period as per regulations. | Administrative Staff, LIMS Administrator | Billing errors, data security breaches, inadequate record retention policies. |
Key Stages of Molecular Diagnostics Lab Process in Mauritius
- Inquiry & Test Ordering
- Sample Collection & Transportation
- Sample Reception & Accessioning
- Pre-analytical Processing (if applicable)
- Nucleic Acid Extraction
- Amplification (e.g., PCR, RT-PCR)
- Detection & Analysis
- Data Interpretation & Reporting
- Quality Assurance & Control
- Billing & Record Keeping
Molecular Diagnostics Labs Cost In Mauritius
Molecular diagnostics laboratories in Mauritius offer a range of tests crucial for diagnosing infectious diseases, genetic conditions, and other health concerns. The cost of these services can vary significantly based on several factors, making it important for individuals to inquire about specific pricing. Generally, these costs are quoted in Mauritian Rupees (MUR).
| Type of Molecular Diagnostic Test (Examples) | Estimated Price Range (MUR) |
|---|---|
| COVID-19 PCR Test | MUR 3,000 - MUR 6,000 |
| Viral Load Testing (e.g., HIV, Hepatitis B/C) | MUR 5,000 - MUR 10,000 |
| Sexually Transmitted Infection (STI) Panel (PCR-based) | MUR 4,000 - MUR 8,000 |
| Basic Genetic Mutation Testing (e.g., for specific inherited conditions) | MUR 8,000 - MUR 15,000 |
| Infectious Disease Identification (e.g., Dengue, Chikungunya) | MUR 3,500 - MUR 7,000 |
| Drug Resistance Testing (e.g., Tuberculosis) | MUR 10,000 - MUR 20,000+ |
Key Pricing Factors for Molecular Diagnostics in Mauritius:
- Type of Test: The complexity and specificity of the molecular test are primary drivers of cost. Basic PCR tests for common viruses are typically less expensive than comprehensive genetic panels or tests for rare diseases.
- Reagents and Technology: The cost of specialized reagents, advanced equipment, and proprietary testing platforms used by the laboratory directly influences the overall price.
- Laboratory Overhead: Operational costs, including rent, utilities, staff salaries (highly skilled technicians and scientists), and quality control measures, are factored into the pricing.
- Turnaround Time: While not always a separate charge, expedited results may incur a premium due to the increased demand on laboratory resources and personnel.
- Inclusion of Consultation: Some labs may bundle the diagnostic test with a consultation fee with a doctor or specialist to interpret the results, which will increase the total cost.
- Accreditation and Quality Standards: Laboratories adhering to international accreditation standards (e.g., ISO) might have slightly higher prices, reflecting their commitment to quality and accuracy.
- Volume and Partnerships: Larger hospitals or clinics that have bulk agreements with diagnostic labs might benefit from slightly reduced rates.
Affordable Molecular Diagnostics Labs Options
Accessing affordable molecular diagnostics labs is crucial for timely and accurate disease detection and management. This can be achieved through various options, with a focus on understanding value bundles and implementing cost-saving strategies. Value bundles often combine multiple tests or services at a reduced overall price compared to individual purchases. Cost-saving strategies involve proactive planning, leveraging available discounts, and exploring different provider models.
| Strategy/Bundle Type | Description | Potential Cost Savings |
|---|---|---|
| Comprehensive Health Panels | Bundles that include a range of common genetic markers, disease predispositions, or wellness indicators. For example, a "Complete Blood Count & Comprehensive Metabolic Panel" bundle. | Often 10-20% lower than purchasing individual tests. Reduces administrative overhead. |
| Infectious Disease Screening Packages | Groupings of tests for common viral, bacterial, or parasitic infections. Example: A 'STI panel' bundle covering multiple pathogens. | Can save 15-25% compared to individual STI tests. Facilitates proactive screening. |
| Prenatal Genetic Screening Bundles | Combine NIPT (Non-Invasive Prenatal Testing) with other genetic carrier screenings. | Offers a holistic genetic overview at a reduced price point, potentially saving hundreds of dollars compared to separate tests. |
| Out-of-Pocket Discount Programs | Labs may offer discounts for patients paying directly, bypassing insurance. Often involves signing up for a loyalty program or paying upfront. | Discounts can range from 5-15% for self-pay patients. |
| Subscription or Membership Models | Some labs offer monthly or annual fees for access to a certain number of tests or discounted pricing on all services. | Can lead to significant savings for individuals who require frequent testing. |
| Negotiated Rates through Employers or Insurance | While not a direct 'bundle' from the lab, group rates negotiated by employers or insurance providers effectively create value bundles for employees/members. | Savings vary widely but can be substantial, often reducing out-of-pocket costs significantly. |
| Telehealth Consultations with Testing Orders | Many telehealth platforms integrate with diagnostic labs. The consultation fee is often less than an in-person visit, and the bundled cost of consultation + testing can be economical. | Can save on copays and travel expenses, with test costs often competitively priced within the telehealth package. |
Options for Affordable Molecular Diagnostics Labs
- {"title":"Direct-to-Consumer (DTC) Testing Services","description":"These services allow individuals to order tests online, often with at-home sample collection kits. While not always the cheapest for complex diagnostics, they can be cost-effective for specific screening tests like certain genetic predispositions or infectious disease panels."}
- {"title":"Partnerships with Healthcare Providers","description":"Many clinics and hospitals have established contracts with specific molecular diagnostic labs, which can lead to discounted pricing for patients covered by their insurance or through negotiated rates. Inquire with your doctor about preferred lab partners."}
- {"title":"Non-profit Organizations and Public Health Initiatives","description":"Some non-profit organizations and government-funded public health programs offer subsidized or free molecular diagnostic testing for specific conditions or underserved populations. This is particularly common for infectious diseases like HIV, hepatitis, or STIs."}
- {"title":"Independent and Specialized Labs","description":"Smaller, independent labs or those specializing in niche molecular tests might offer more competitive pricing than large, established diagnostic companies. Researching and comparing options from various providers is key."}
- {"title":"Academic Medical Centers","description":"Teaching hospitals and academic medical centers often have in-house molecular diagnostic capabilities and may offer services at a lower cost, especially for research-related tests or if you are a patient within their system."}
Verified Providers In Mauritius
In Mauritius, ensuring the quality and legitimacy of healthcare providers is paramount. Franance Health stands out as a beacon of trust, meticulously vetting and credentialing healthcare professionals and institutions. This rigorous process guarantees that individuals seeking medical services through Franance Health can do so with absolute confidence in the expertise, ethical standards, and operational integrity of their chosen providers. Their commitment to verified credentials not only simplifies the patient's choice but also elevates the overall standard of healthcare delivery in Mauritius.
| Credential Type | Verification Process | Significance for Patients |
|---|---|---|
| Medical Licenses & Registrations | Thorough checks with relevant regulatory bodies in Mauritius. | Confirms legal authorization to practice and adherence to professional standards. |
| Academic & Professional Qualifications | Verification of degrees, diplomas, and specialized training from accredited institutions. | Ensures providers possess the foundational knowledge and expertise required for their field. |
| Experience & Practice History | Review of past employment, practice affiliations, and professional references. | Provides insight into a provider's practical experience and reputation within the medical community. |
| Ethical Compliance & Disciplinary Records | Screening for any past disciplinary actions or ethical breaches. | Guarantees that providers adhere to the highest ethical principles in patient care. |
| Continuing Medical Education (CME) | Confirmation of ongoing participation in professional development programs. | Demonstrates a commitment to staying updated with the latest medical advancements and best practices. |
Why Franance Health Credentials Matter:
- Uncompromising Quality Assurance: Franance Health's credentialing process involves a deep dive into qualifications, licenses, certifications, and continuous professional development of all listed providers.
- Patient Safety First: By verifying backgrounds and adhering to strict ethical guidelines, Franance Health significantly reduces the risk associated with seeking medical care.
- Enhanced Trust and Transparency: Patients gain peace of mind knowing they are engaging with verified professionals, fostering a transparent and trustworthy healthcare ecosystem.
- Access to Top-Tier Expertise: Franance Health identifies and partners with leading medical practitioners and facilities, ensuring access to specialized knowledge and advanced treatments.
- Streamlined Healthcare Navigation: The platform simplifies the daunting task of finding reliable healthcare, allowing individuals to focus on their well-being.
Scope Of Work For Molecular Diagnostics Labs
This Scope of Work (SOW) outlines the technical deliverables and standard specifications required for the establishment and operation of Molecular Diagnostics Laboratories. It covers critical aspects from infrastructure and equipment to workflow, quality control, and data management, ensuring the delivery of accurate, reliable, and timely molecular diagnostic testing services.
| Parameter | Specification/Requirement | Verification Method |
|---|---|---|
| Nucleic Acid Extraction Yield | Minimum of X ng/µL for typical samples | Spectrophotometry (e.g., NanoDrop) |
| PCR Inhibitor Assessment | No significant inhibition detected at Z µL input | Dilution studies with spiked samples |
| Real-time PCR Instrument Sensitivity | Detection of < 10 copies of target DNA/RNA | Analytical sensitivity testing with serial dilutions of standards |
| Assay LoD (Limit of Detection) | As per validation protocol (e.g., 95% detection at X copies/reaction) | Probit analysis using serial dilutions |
| Assay LoQ (Limit of Quantification) | As per validation protocol (e.g., CV < 20% at X copies/reaction) | Probit analysis using serial dilutions |
| Instrument Calibration | Regular calibration as per manufacturer's recommendations and SOPs | Calibration certificates, logs |
| Biosafety Cabinet Certification | Annual certification by accredited personnel | Certification reports |
| Temperature Monitoring Devices | Calibrated and validated with traceable standards | Calibration certificates, logs |
| LIMS Audit Trail | Records all user actions, timestamps, and data changes | LIMS software configuration review |
| Staff Competency | Demonstrated proficiency in all assigned tasks | Competency assessment records, proficiency testing results |
Key Deliverables and Specifications
- {"items":["Compliance with relevant biosafety levels (BSL-2, BSL-3 as applicable).","Segregated workflow areas (pre-PCR, PCR, post-PCR).","Adequate ventilation and air handling systems (HEPA filtration, negative pressure where required).","Dedicated and validated power supply with backup (UPS, generator).","Water purification systems meeting molecular biology standards (e.g., Type I ultrapure water).","Robust waste management and decontamination protocols."],"title":"Laboratory Infrastructure and Design"}
- {"items":["Automated nucleic acid extraction systems.","Real-time PCR (qPCR) or digital PCR (dPCR) instruments with validated performance.","Thermocyclers (for endpoint PCR if applicable).","Automated liquid handling robots.","Centrifuges, vortex mixers, incubators, and biosafety cabinets (Class II minimum).","Microscopes (if applicable for sample preparation).","Refrigerators and freezers (-20°C, -80°C) with temperature monitoring and alarms.","Autoclaves for sterilization.","Computer workstations and network infrastructure."],"title":"Equipment and Instrumentation"}
- {"items":["Validated and certified nucleic acid extraction kits.","High-performance PCR master mixes and primers/probes (validated for target analytes).","Positive and negative controls (internal and external).","Certified reference materials for method validation and ongoing QC.","Sterile disposable consumables (tubes, tips, plates) certified nuclease-free.","Strict inventory management and expiry date tracking."],"title":"Reagents and Consumables"}
- {"items":["Development of in-house assays or validation of commercially available kits.","Comprehensive analytical validation (limit of detection, limit of quantification, linearity, accuracy, precision, specificity, inclusivity/exclusivity).","Clinical validation with appropriate patient sample cohorts.","Establishment of cut-off values and interpretation guidelines.","Documentation of all validation protocols and reports."],"title":"Assay Development and Validation"}
- {"items":["Detailed SOPs for sample reception, processing, extraction, amplification, detection, and reporting.","Strict adherence to pre-analytical, analytical, and post-analytical phases.","Dedicated reagents and equipment for distinct assay types to prevent cross-contamination.","Workflow optimization for throughput and turnaround time.","Regular review and update of SOPs."],"title":"Workflow and Standard Operating Procedures (SOPs)"}
- {"items":["Implementation of a comprehensive QMS aligned with ISO 15189 or CLIA standards.","Regular internal and external quality assessment (EQA/PT) participation.","Daily QC checks on instruments, reagents, and critical reagents.","Establishment of control charts and action limits.","Proficiency testing for all performed assays.","Root cause analysis and corrective action for QC failures.","Regular staff competency assessment."],"title":"Quality Management System (QMS) and Quality Control (QC)"}
- {"items":["Laboratory Information Management System (LIMS) for sample tracking, data entry, and reporting.","Secure data storage with regular backups and disaster recovery plan.","Audit trails for all data manipulations and changes.","Interfacing capabilities with hospital/clinic Electronic Health Records (EHR) systems (HL7 compliance).","Robust cybersecurity measures to protect patient data.","Secure reporting mechanisms (e.g., encrypted PDFs, secure portal)."],"title":"Data Management and Information Technology (IT)"}
- {"items":["Qualified and experienced laboratory personnel (technologists, scientists, technicians).","Ongoing training programs on new technologies, assays, and safety protocols.","Documentation of all training records.","Defined roles and responsibilities for all personnel.","Adherence to ethical guidelines and patient confidentiality."],"title":"Personnel and Training"}
- {"items":["Adherence to local, national, and international regulatory requirements (e.g., CAP, CLIA, FDA if applicable).","Maintenance of all necessary licenses and accreditations.","Regular audits and inspections by regulatory bodies.","Documentation of compliance with all relevant guidelines."],"title":"Regulatory Compliance"}
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for molecular diagnostic laboratory services provided by [Your Company Name] to [Client Name]. This SLA is effective as of [Start Date] and will remain in effect until [End Date].
| Service Component | Response Time Guarantee (Business Hours) | Uptime Guarantee |
|---|---|---|
| Initial Assay Setup & Validation | Within 4 business hours of sample receipt and validation | N/A (one-time event) |
| Routine Test Results Reporting | Within 72 business hours of sample receipt for most assays (specific turnaround times per assay listed in Appendix A) | 99.5% availability during scheduled operational hours |
| Urgent/STAT Test Results Reporting | Within 24 business hours of sample receipt (prior notification required) | 99.8% availability during scheduled operational hours |
| Technical Support (Phone/Email) | Within 2 business hours during standard operating hours | 99.9% availability during standard operating hours |
| Data Analysis & Interpretation | Integrated with test reporting times, as specified in Appendix A | 99.5% availability of analysis platforms |
Scope of Services Covered
- Routine diagnostic testing (e.g., PCR, sequencing, NGS analysis).
- Urgent/STAT diagnostic testing.
- Data analysis and reporting for all covered tests.
- Technical support for assay interpretation and troubleshooting.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Mauritius project in Mauritius.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.